• The Company
    • Mission Statement
    • Company Background
    • Leadership Team
    • Board of Directors
    • Strategic Advisors
    • Careers
  • The Clinical Problem
    • Mechanical Ventilation & the ICU
    • Diaphragmatic Atrophy & VIDD
    • Ventilator Weaning
    • Weaning Classifications
    • Economic Impact of VIDD
  • pdSTIM™ System
    • System Overview
    • System Components
    • Therapy Set-up & Implementation
  • Clinical Study
  • News and Events
  • Contact Us

Stimdia engages Minnetronix Medical to develop and manufacture beta console for pdSTIM System

by larryyost | May 6, 2017 | News

What’s New

  • Now Published – “The ReInvigorate Study—phrenic nerve-to-diaphragm stimulation for weaning from mechanical ventilation: a protocol for a randomized pivotal clinical trial”
  • Stimdia Medical Inc. Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients
  • Stimdia Medical Announces Close of Series B Equity Financing Round with Proceeds to be Used to Complete the Company’s Pivotal Study
  • Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation
  • Results of PEPNS study published in Critical Care Medicine, official journal of the Society of Critical Care Medicine (SCCM)

CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use

Privacy Policy

Terms of Use



1355 Mendota Heights Road, Suite 300, Mendota Heights MN 55120



info [at] stimdia [dot] com

Stimulating Patients to Facilitate Breathing on Their Own

© 2024 Stimdia Medical Inc.  | All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok